CIK 0001728328 · <br>Emerging growth company
InMed Pharmaceuticals Inc.
Sign in to watch- Tickers
- INM MTRI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (604) 669-7207
- Business address
- C/O NORTON ROSE FULBRIGHT CANADA LLP, SUITE 1800 - 510 WEST GEORGIA STREET, VANCOUVER, British Columbia, Canada, V6B 0M3
Securities
- INM Common stock Nasdaq
- MTRI Common Stock Nasdaq
- Open-market buys, last 90 days
- $238,371
- in 7 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$238,371. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 23 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-11-14 | Johnson Shane Aaron Sr VP & General Manager | Returned to the company · Employee Stock Option (Right to Buy) | −4,200 | 3,800 | ||
| 2022-11-14 | MANCINI ALEXANDRA DIANE JANET Sr VP, Clinical Reg Affairs | Returned to the company · Employee Stock Option (Right to Buy) | −4,200 | 3,952 | ||
| 2022-11-14 | HSU ERIC C Sr. VP, Pre-Clinical Res/Dev | Returned to the company · Employee Stock Option (Right to Buy) | −4,200 | 4,678 | ||
| 2022-11-14 | ADAMS ERIC A President & CEO | Returned to the company · Employee Stock Option (Right to Buy) | −15,000 | 13,502 | ||
| 2022-11-14 | WOUDENBERG MICHAEL Chief Operating Officer | Returned to the company · Employee Stock Option (Right to Buy) | −7,500 | 3,842 | ||
| 2022-11-14 | Johnson Shane Aaron Sr. VP & General Manager | Grant or award · Employee Stock Option (Right to Buy) | +4,200 | 8,000 | ||
| 2022-11-14 | WOUDENBERG MICHAEL Chief Operating Officer | Grant or award · Employee Stock Option (Right to Buy) | +7,500 | 11,342 | ||
| 2022-11-14 | HSU ERIC C Sr. VP, Pre-Clinical Res/Dev | Grant or award · Employee Stock Option (Right to Buy) | +4,200 | 8,878 | ||
| 2022-11-14 | ADAMS ERIC A President & CEO | Grant or award · Employee Stock Option (Right to Buy) | +15,000 | 28,502 | ||
| 2022-11-14 | MANCINI ALEXANDRA DIANE JANET Sr VP, Clinical Reg Affairs | Grant or award · Employee Stock Option (Right to Buy) | +4,200 | 8,152 | ||
| 2022-08-10 | Lemerond Nicole Director | Grant or award · Employee Stock Option (Right to Buy) | +14,000 | 14,000 | ||
| 2022-06-02 | MANCINI ALEXANDRA DIANE JANET Sr VP, Clinical Reg Affairs | Other disposition · Employee Stock Option (Expiration) | −1,515 | 98,787 | ||
| 2022-06-02 | ADAMS ERIC A President & CEO | Other disposition · Employee Stock Option (Expiration) | −13,636 | 337,576 | ||
| 2022-05-17 | Baldasare Bryan T Director | Grant or award · Employee Stock Option (Right to Buy) | −14,000 | 14,000 | ||
| 2022-04-14 | ADAMS ERIC A President & CEO | Purchase | +14,160 | $0.89 | $13K | 59,003 |
| 2022-04-13 | ADAMS ERIC A President & CEO | Purchase | +8,560 | $0.85 | $7K | 44,843 |
| 2022-02-23 | WOUDENBERG MICHAEL See Remarks | Grant or award · Employee Stock Option (Right to Buy) | +5,000 | 96,060 | ||
| 2022-02-20 | MANCINI ALEXANDRA DIANE JANET Sr VP, Clinical Reg Affairs | Other disposition · Employee Stock Option (Expiration) | −3,030 | 100,302 | ||
| 2022-02-18 | Grove Janet P Director | Grant or award · Employee Stock Option (Right to Buy) | +14,000 | 14,000 | ||
| 2022-01-24 | Garner William J Director | Other disposition · Employee Stock Option (Expiration) | −24,242 | 16,122 |
Page 7 of 8 · 149 trades